Gilles Folléa

Patient Blood Management

Markus M. Mueller, Hans Van Remoortel, Patrick Meybohm et al. · JAMA · 2019 · 595 citations

Frequency and Clinical Implications of Development of Donor-Specific and Non–Donor-Specific HLA Antibodies after Kidney Transplantation

Maryvonne Hourmant, Anne Cesbron‐Gautier, Paul I. Terasaki et al. · Journal of the American Society of Nephrology · 2005 · 292 citations

Hla, Histocompatibility, Clinical Implications +22

Determinants of transfusion‐associated bacterial contamination: results of the French B<scp>acthem</scp> Case‐Control Study

Paul Perez, Louis‐Rachid Salmi, Gilles Folléa et al. · Transfusion · 2001 · 201 citations

A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology

Jean‐Pierre Cazenave, Gilles Folléa, Laurent Bardiaux et al. · Transfusion · 2010 · 167 citations

Relevance of KIR gene polymorphisms in bone marrow transplantation outcome

Katia Gagne, Géraldine Brizard, B. Gueglio et al. · Human Immunology · 2002 · 151 citations

Transplantation, Marrow Transplantation, Genetics +10